We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Biopharma

ProtonDx

ProtonDx's core technology builds on years of innovative research on diagnostics and sample processing, fuelled by unique collaborations between engineering, medicine and molecular biology. The spinout company was founded in 2020 at Imperial College London.

Latest Content

Illustration of malaria parasite with red blood cell, symbolizing Dragonfly test for detecting hidden malaria infections.

Product News

ProtonDx’s Dragonfly Evaluated To Detect Hidden Malaria Cases

ProtonDx’s Dragonfly enables rapid detection of asymptomatic malaria infections, advancing global malaria elimination strategies.

Never miss a story

with the Breaking Science News daily newsletter